Long-acting antituberculous therapeutic nanoparticles target macrophage endosomes.
about
Cellular Responses and Tissue Depots for Nanoformulated Antiretroviral TherapyOpposing regulation of endolysosomal pathways by long-acting nanoformulated antiretroviral therapy and HIV-1 in human macrophagesProlonged-acting, multi-targeting gallium nanoparticles potently inhibit growth of both HIV and mycobacteria in co-infected human macrophages.Preparation, characterization, and safety evaluation of poly(lactide-co-glycolide) nanoparticles for protein delivery into macrophages.Long-acting slow effective release antiretroviral therapy.Gallium nanoparticles facilitate phagosome maturation and inhibit growth of virulent Mycobacterium tuberculosis in macrophages.Ga(III) Nanoparticles Inhibit Growth of both Mycobacterium tuberculosis and HIV and Release of Interleukin-6 (IL-6) and IL-8 in Coinfected Macrophages.Nanoparticle-based local antimicrobial drug delivery.Cytotoxicity assessment, inflammatory properties, and cellular uptake of Neutraplex lipid-based nanoparticles in THP-1 monocyte-derived macrophages.Development of arginine based nanocarriers for targeting and treatment of intracellular Salmonella
P2860
Q28551873-173ED680-D7C4-4D7E-9F03-2B9CF500C170Q35016131-AB6D1D6C-8579-4836-8437-8574E3AC6745Q35153311-FD455862-7428-4AD6-B8D0-4F31E93BDF67Q36111190-5E02C319-8FBD-45A2-A506-641FAE4EF02AQ36262152-66305450-A6C1-4A70-A9E8-AAF7E34544EAQ36381046-53E20B55-26F4-479E-A1BE-6D0CF842460DQ37720824-106A20F8-C5C2-4B71-BF18-13CCD2C321DEQ46223691-136DC71B-4324-4F11-9026-49C1A0BDBC51Q55286937-E29EE6A7-C987-437E-AE5C-25634FF2D948Q57173172-606816C5-7632-46D6-88DB-E55956AB3891
P2860
Long-acting antituberculous therapeutic nanoparticles target macrophage endosomes.
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Long-acting antituberculous therapeutic nanoparticles target macrophage endosomes.
@ast
Long-acting antituberculous therapeutic nanoparticles target macrophage endosomes.
@en
Long-acting antituberculous therapeutic nanoparticles target macrophage endosomes.
@nl
type
label
Long-acting antituberculous therapeutic nanoparticles target macrophage endosomes.
@ast
Long-acting antituberculous therapeutic nanoparticles target macrophage endosomes.
@en
Long-acting antituberculous therapeutic nanoparticles target macrophage endosomes.
@nl
prefLabel
Long-acting antituberculous therapeutic nanoparticles target macrophage endosomes.
@ast
Long-acting antituberculous therapeutic nanoparticles target macrophage endosomes.
@en
Long-acting antituberculous therapeutic nanoparticles target macrophage endosomes.
@nl
P2093
P2860
P356
P1433
P1476
Long-acting antituberculous therapeutic nanoparticles target macrophage endosomes
@en
P2093
Benson J Edagwa
Howard E Gendelman
JoEllyn McMillan
Pavan Puligujja
Xinming Liu
P2860
P304
P356
10.1096/FJ.14-255786
P407
P577
2014-08-13T00:00:00Z